We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.12B
AUM Growth
+$54.5M
Cap. Flow
+$26.3M
Cap. Flow %
2.35%
Top 10 Hldgs %
29.48%
Holding
398
New
28
Increased
109
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.6M
2
PYPL icon
PayPal
PYPL
+$8.22M
3
GILD icon
Gilead Sciences
GILD
+$7.14M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.62M
5
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$2.36M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
URI icon
United Rentals
URI
+$6.93M
3
LMT icon
Lockheed Martin
LMT
+$2.69M
4
AAPL icon
Apple
AAPL
+$2.39M
5
VNLA icon
Janus Henderson Short Duration Income ETF
VNLA
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 18.15%
2 Technology 17.83%
3 Financials 12.37%
4 Industrials 9.95%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVEM icon
26
Avantis Emerging Markets Equity ETF
AVEM
$25.6B
$16.9M 1.51%
313,923
+44,303
+16% +$2.36M
AVIV icon
27
Avantis International Large Cap Value ETF
AVIV
$2.01B
$16.8M 1.5%
345,488
+29,573
+9% +$1.44M
APTV icon
28
Aptiv
APTV
$12B
$16.1M 1.44%
157,921
+959
+0.6% +$94.8K
PNC icon
29
PNC Financial Services
PNC
$100B
$15.8M 1.41%
125,267
+243
+0.2% +$29.7K
FV icon
30
First Trust Dorsey Wright Focus 5 ETF
FV
$3.63B
$15.7M 1.4%
334,662
-5,642
-2% -$252K
LOW icon
31
Lowe's Companies
LOW
$117B
$15.3M 1.37%
67,730
+1,180
+2% +$245K
TPYP icon
32
Tortoise North American Pipeline ETF
TPYP
$868M
$14.9M 1.33%
604,358
+6,395
+1% +$156K
LDOS icon
33
Leidos
LDOS
$14.9B
$14.4M 1.29%
162,470
+2,090
+1% +$178K
WMT icon
34
Walmart Inc
WMT
$879B
$14.4M 1.28%
274,161
+9,096
+3% +$459K
GHYB icon
35
Goldman Sachs Access High Yield Corporate Bond ETF
GHYB
$133M
$13.9M 1.25%
324,697
+8,456
+3% +$361K
GSIE icon
36
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.02B
$13.1M 1.18%
419,279
-5,934
-1% -$186K
UTHR icon
37
United Therapeutics
UTHR
$25.7B
$13M 1.16%
58,989
+430
+0.7% +$95.2K
IMTM icon
38
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.16B
$12.1M 1.08%
363,782
-5,256
-1% -$173K
BIIB icon
39
Biogen
BIIB
$29.8B
$11.9M 1.06%
41,702
+1,014
+2% +$302K
GBIL icon
40
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.57B
$11.3M 1.01%
113,380
+8,065
+8% +$806K
VCSH icon
41
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
$10.7M 0.96%
141,960
+2,360
+2% +$179K
LHX icon
42
L3Harris
LHX
$51.4B
$10.5M 0.94%
53,643
+570
+1% +$109K
IGSB icon
43
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$10.3M 0.92%
204,745
+4,770
+2% +$240K
SHYG icon
44
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.59B
$9.81M 0.88%
236,697
+3,425
+1% +$141K
VNLA icon
45
Janus Henderson Short Duration Income ETF
VNLA
$3.35B
$9.62M 0.86%
201,210
-16,864
-8% -$805K
GRMN
46
Garmin
GRMN
$57.9B
$9.48M 0.85%
90,923
+858
+1% +$87.7K
AVDV icon
47
Avantis International Small Cap Value ETF
AVDV
$19B
$9.38M 0.84%
163,025
+25,590
+19% +$1.5M
GSY icon
48
Invesco Ultra Short Duration ETF
GSY
$3.9B
$8.59M 0.77%
173,028
-2,850
-2% -$142K
JMBS icon
49
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.7B
$7.64M 0.68%
167,054
+3,205
+2% +$148K
BDX icon
50
Becton Dickinson
BDX
$46.4B
$7.17M 0.64%
27,153
+75
+0.3% +$19K
1
2
3 4 5

Similar funds

PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM

Atwood & Palmer's Q2 2023 Portfolio in Review

As of Q2 2023, Atwood & Palmer held 398 positions worth $1.12B, up 5.1% from $1.06B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Atwood & Palmer's Q2 2023 filing shows 28 new, 109 increased, 39 reduced and 2 closed positions. Its largest new stake was Vertex Pharmaceuticals: 52,175 shares worth $18.4M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q2 2023 buy was Vertex Pharmaceuticals: 52,175 shares worth $18.4M.
  • Atwood & Palmer added most to PayPal in Q2 2023, an estimated $8.22M increase.
  • Atwood & Palmer's biggest Q2 2023 reduction was Amgen, cutting an estimated $19.6M.
  • Atwood & Palmer fully exited First Trust Materials AlphaDEX Fund in Q2 2023, selling an estimated $217K.
  • Atwood & Palmer's ten largest holdings make up 29% of its $1.12B portfolio in Q2 2023.
  • Atwood & Palmer opened 28 new positions and closed 2 in Q2 2023.
  • Atwood & Palmer's portfolio value rose 5.1% quarter-over-quarter to $1.12B.

Based on Atwood & Palmer's 13F filing for Q2 2023, filed 18 Jul 2023.